ImmunoPhotonics develops immunotherapy-based treatments for cancer.
ImmunoPhotonics has raised $1.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2024.
ImmunoPhotonics's investors include Cultivation Capital, iSelect Fund, Arch Grants, BioGenerator, Tech Coast Angels.
ImmunoPhotonics is headquartered in Columbia, United States.
ImmunoPhotonics develops immunotherapy-based treatments for cancer.
ImmunoPhotonics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ImmunoPhotonics — Funding & Investors." VCBacked, March 15, 2024, https://www.vcbacked.co/company/immunophotonics. Accessed November 13, 2026.
VCBacked. (2024). ImmunoPhotonics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/immunophotonics
{{cite web |title=ImmunoPhotonics — Funding & Investors |url=https://www.vcbacked.co/company/immunophotonics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at ImmunoPhotonics? Request a listing update